rdf:type |
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0005508,
umls-concept:C0034656,
umls-concept:C0240339,
umls-concept:C0524527,
umls-concept:C0681850,
umls-concept:C0983010,
umls-concept:C0991537,
umls-concept:C0993159,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1707455,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-8-13
|
pubmed:abstractText |
Acyclovir is an important antiviral drug, used extensively for treatment of herpes simplex and varicella zoster. Six oral generic formulations of acyclovir are available in Mexico; however, a literature search failed to identify data information concerning the bioavailability of these formulations in the Mexican population.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0149-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1146-52
|
pubmed:meshHeading |
pubmed-meshheading:17692728-Acyclovir,
pubmed-meshheading:17692728-Administration, Oral,
pubmed-meshheading:17692728-Adolescent,
pubmed-meshheading:17692728-Adult,
pubmed-meshheading:17692728-Antiviral Agents,
pubmed-meshheading:17692728-Area Under Curve,
pubmed-meshheading:17692728-Biological Availability,
pubmed-meshheading:17692728-Chemistry, Pharmaceutical,
pubmed-meshheading:17692728-Chromatography, High Pressure Liquid,
pubmed-meshheading:17692728-Cross-Over Studies,
pubmed-meshheading:17692728-Drug Administration Schedule,
pubmed-meshheading:17692728-Female,
pubmed-meshheading:17692728-Humans,
pubmed-meshheading:17692728-Male,
pubmed-meshheading:17692728-Mexico,
pubmed-meshheading:17692728-Middle Aged,
pubmed-meshheading:17692728-Reference Values,
pubmed-meshheading:17692728-Suspensions,
pubmed-meshheading:17692728-Tablets,
pubmed-meshheading:17692728-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
|
pubmed:affiliation |
Centro de Estudios Científicos y Clínicos Pharma, S.A. de C.V., Mexico City, Mexico.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|